https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-24 13:37:292022-07-02 10:31:53In a long-term study, new data show that Givinostat continues to delay the progression of Duchenne disease.
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-16 08:56:582021-08-23 11:39:49RGX-202 for the treatment of Duchenne muscular dystrophy (DMD)
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-16 08:31:292021-08-23 11:40:08Approval of accelerated treatment of voiltolarsen for Duchenne muscular dystrophy by the FDA
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-16 08:11:222022-07-02 10:37:12Losmapimod for FSHD patients by Fulcrum
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-16 08:02:122021-08-23 11:40:40Exondys 51 or eteplirsen for the treatment of patients with Duchenne Exon 51
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-16 07:29:452021-08-23 11:40:50FDA Accepts IND for Limb-Girdle Muscular Dystrophy Gene Therapy
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-15 14:16:152021-08-23 11:41:00Invest in cell therapy for muscular dystrophic diseases, especially LGMD2A
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-15 13:49:292021-08-23 11:41:10Gene modification holds good promise for the treatment of Duchenne disease
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
0
0
admin
https://neuromuscular-iran.ir/wp-content/uploads/2021/02/logo_neuromuscular-300x138.png
admin2021-08-15 10:31:582021-08-23 11:41:20Clinical trial findings show that vamorolone confidently improves muscle function in Duchenne boys
Scroll to top
